The report noted a strong quarterly dividend history at Gilead Sciences Inc, and favorable long-term multi-year growth rates in key fundamental data points. The annualized dividend paid by Gilead ...
Feb 11 (Reuters) - Gilead Sciences (GILD.O), opens new tab posted fourth-quarter results that exceeded Wall Street expectations and forecast 2025 earnings above analyst estimates on Tuesday ...
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback